DISARM partner VOC Diagnostics helps to show that ovarian cancer can be detected from blood plasma using an AI-driven electronic nose - no biomarkers needed. Exactly the innovation we need for earlier detection 💙 🔗Read more: researchgate.net/publication/... #HaDEA #CancerMission

🎥 DISARM Interview Series – Episode 3 We spoke with Fatima Vaz on IPOLisboa’s role in DISARM, her expertise as a medical oncologist, and the innovative technologies being tested as part of the project. 🎬 Watch: youtu.be/Hpjs6EqzfdE #HaDEA #CancerMission

🎥 Our second DISARM interview video is live! In this video, Laura Caretto of EVITA discusses her role in the project, the project's Citizen Awareness Campaign, and what she is most excited about as DISARM moves forward. 🎬 Watch the interview here: youtu.be/i3pRl4qngjY?... #HaDEA #CancerMission

🎁 It’s time to unwrap our Christmas present! The official DISARM project website is now live — bringing together our mission, partners & progress in one place. 🔗 Visit: Home | disarm-project.eu #HaDEA #CancerMission

🎅 An early holiday surprise… The DISARM project’s official website is launching very soon, bringing together all our project information, project partners, and updates in one place. Stay tuned — the wrapping is coming off shortly! 🎁 #HaDEA #CancerMission

Our partner, the World Ovarian Cancer Coalition, has released the first findings of the Every Woman Study: LMIC Edition — revealing critical disparities in awareness, diagnosis, and access to care for the majority of women worldwide living with ovarian cancer 📄 www.thelancet.com/journals/lan...

📄 We're proud to share that Jens Eriksson, a DISARM partner with VOC Diagnostics, co-authored a study showing ML-driven VOC analysis can detect ovarian & endometrial cancer with high accuracy - even early. Includes refinements for DISARM’s OVA-VOC assay. www.sciencedirect.com/science/arti...

We’re pleased to share that Zdenek Kleibl of @charlesuni.cuni.cz took part in the 2025 CSBMB Annual Symposium in Nanchang, China (23–26 Oct). He also presented the DISARM project, sharing its goals and research with an international audience. 📸 Photos below! #HaDEA #CancerMission

🎥 Our first DISARM interview is live! The video features Clara MacKay, CEO of the World Ovarian Cancer Coalition, who shares her role in the project & what excites her most about DISARM’s mission to advance early detection. Watch here 👇 youtube.com/watch?v=Iwn7vzSuRZA&feature=youtu.be

Knowing the symptoms of #OvarianCancer can save lives — please take a moment to watch and share @targetovarian.bsky.social's video over on X and visit their website so more people can recognise the signs early. 💙 #HaDEA #CancerMission x.com/i/status/199...

We were thrilled to present the DISARM project at IPO Lisbon on 31st October! 🎉 If you weren’t able to attend but want to learn more, please feel free to contact the Communication and Dissemination Manager, Ben Moore, at [email protected] #HaDEA #CancerMission

We are proud to share that the @cancerletter.com has featured the first press release from DISARM 📰 A big thank you to them for helping spread word of our project that aims to advance early detection & risk assessment for ovarian cancer 💙 #HaDEA #CancerMission cancerletter.com/clinical-rou...

On October 31, the DISARM project will be presented at the IPO Lisbon Research Meeting, introducing a major step forward in the early detection of ovarian cancer. ✍️Sign up here: lnkd.in/dTfRAinJ #HaDEA #CancerMission

We’re proud to share that ecancer, a leading oncology education platform, has featured the first press release from DISARM — our EU-funded project focused on improving risk assessment and early detection in ovarian cancer 📰 #HaDEA #CancerMission ecancer.org/en/news/2717...

The DISARM project was recently featured on Portugal’s national TV channel RTP, highlighting efforts to improve early detection of ovarian cancer. 💙 Watch the full piece here 👇 www.rtp.pt/noticias/pai...

Exciting news! 📰 The DISARM project has been featured by the Greek outlet Dnews, highlighting the importance of early detection, risk assessment, and smart digital tools for tacking ovarian cancer 💙 www.dnews.gr/eidhseis/sci...

Go behind the scenes of the DISARM project’s official kick-off meeting in Athens! 🎬 See the collaboration, energy, and shared commitment driving our mission to transform ovarian cancer risk assessment and early detection 💙 www.youtube.com/watch?v=xvrm...

That’s a wrap on the #DISARM kick-off in Athens! 2 days of collaboration, keynotes & big ideas: 🏛️ Ovarian cancer socioececonomic burden & the CanRisk tool 🔬 Liquid biopsy & clinical studies 🧬 PRS adaptation 👥 Citizen awareness & Platforms An Exciting journey ahead , thank you to all partners! 💙

Day 2 of the #DISARM kick-off in Athens! 🏛️ We open with a keynote from Prof. Antonis Antoniou (University of Cambridge) on the CanRisk tool. Today’s agenda: risk assessment in clinical studies, citizen awareness, strategies for adapting PRS to national populations and more!

Day 1 of the #DISARM kick-off is complete! 🚀 This afternoon, partners aligned on clinical protocols and explored opportunities for policy development. More updates coming tomorrow, stay tuned!

A busy and engaging morning here in Athens, with an insightful keynote presentation from Clara MacKay on the socioeconomic burden of ovarian cancer 📰 This was followed by a fruitful discussion on liquid biopsy detection from our partners UNRF 👨‍🏫 Stay tuned for more updates throughout the day!

καλημέρα από Αθήνα 🇬🇷 This morning our Project Partners have gathered in Greece for the Disarm kick off meeting. This morning's highlight is a keynote presentation from the World Ovarian Cancer Coalition on ‘The Socioeconomic Burden of Ovarian Cancer’. ⚕️ ➡️ Follow for more updates!

The DISARM consortium is looking forward to meeting in Athens on 2–3 October for our official kick-off! 🇬🇷 We’re bringing partners together from across Europe to set the stage for advancing ovarian cancer risk assessment & early detection 🧬 Stay tuned for updates from Athens!

We’re excited to see a piece on DISARM featured with @imperialcollegeldn.bsky.social's Imperial News, showcasing our mission to tackle ovarian cancer through better risk assessment and early detection 📰 🔗 Read the full feature here: www.imperial.ac.uk/news/268373/...

A huge thanks to the @ec.europa.eu for spotlighting the launch of DISARM in their European Cancer Mission Implementation newsletter! 📰 It was wonderful to be featured alongside so many amazing projects under the EU's Cancer Mission 💙 ec.europa.eu/newsroom/rtd...

What a team! 📸 On Monday, the DISARM consortium held a pre–kick-off online meeting to align on admin, financial & work package details, setting a strong base before our in-person kick-off in Athens next month. 🇬🇷 Stay tuned for more from our kick-off! #HorizonEurope #OvarianCancer

A big thank you to @lifesciencenet.bsky.social for featuring our press release on their website! 💻 If you haven't already, check out DISARM's first press release by clicking on the link below 🔗 www.lifescience.net/news/6551/ne...

Perhaps it's fitting that DISARM launched during Gynaecological Cancer Awareness month ♀️ Ovarian cancer is the deadliest gynaecological disease & 8th most common cancer for women globally. We are changing how risk is assessed, bringing proven tech to routine care while validating new approaches💙

We are pleased to share the first press release of the DISARM project 📰 DISARM, aims to advance risk assessment and early detection of ovarian cancer, aiming to make these life-saving approaches part of routine healthcare 🩺 Check it out below! www.linkedin.com/pulse/press-...

We are proud to launch DISARM, a new Horizon Europe project tackling #OvarianCancer through earlier detection and better risk assessment 🧬♀️ With proven solutions & testing new innovations, DISARM aims to transform screening and give patients the best chance at survival 💙